Cochlear sees Oticon Medical merger review extended by UK regulator
MLex Summary: The UK merger review of Cochlear’s acquisition of Oticon Medical, the hearing implant division of Demant, has been extended. The Competition and Markets Authority's deadline has moved to July 31 from...To view the full article, register now.
Already a subscriber? Click here to view full article